Clarinaze Allergy Control 0.05% Nasal Spray 60 Sprays
Product features ##features## Relieves nasal congestion, sneezing, itching, and a runny nose caused by hay fever and year-round allergies including house dust mite, pet dander, and mould Contains mometasone furoate 50 micrograms per actuation, a corticosteroid that works directly in the nasal passages with less than 1% systemic absorption Once-daily dosing with a clinically demonstrated onset of action within 12 hours of the first dose in some patients ##end-features## Product description Clarinaze Allergy Control 0.05% Nasal Spray is a once-daily corticosteroid nasal spray containing mometasone furoate, used to relieve the nasal symptoms of hay fever and perennial allergic rhinitis in adults aged 18 and over. Allergic rhinitis causes inflammation of the nasal lining in response to allergens such as grass pollen, tree pollen, house dust mite, pet hair, feathers, and mould. That inflammation is what produces the characteristic symptoms: a blocked or runny nose, persistent sneezing, and itching inside the nasal passages. Mometasone furoate, the active ingredient in Clarinaze, works by inhibiting the release of the inflammatory mediators that drive this allergic response, reducing swelling and irritation directly at the site where it occurs. Because the spray acts locally within the nasal passages, systemic absorption is less than 1%, making it well tolerated for regular use. In some patients with seasonal allergic rhinitis, a clinically significant improvement in symptoms was observed within 12 hours of the first dose, though full therapeutic benefit may take up to 48 hours to establish. For those with a history of moderate to severe seasonal symptoms, treatment may be started a few days before the expected onset of the pollen season. The recommended starting dose is two sprays in each nostril once daily. Once symptoms are under control, the dose may be reduced to one spray in each nostril once daily as a maintenance dose. Each 10g bottle contains 60 actuations and should be discarded within two months of first use. Features of Clarinaze Allergy Control 0.05% Nasal Spray 60 Sprays Active ingredient: mometasone furoate 50 micrograms per actuation, a topical corticosteroid with local anti-inflammatory action and less than 1% systemic bioavailability Aqueous nasal spray suspension in a metered-dose pump delivering a consistent, measured dose with each actuation CFC-free formulation, free from chlorofluorocarbon propellants 10g bottle providing 60 actuations, to be discarded within 2 months of first opening ##accordion-start## Specifications Active ingredient: mometasone furoate 50 micrograms per actuation (0.05%) Volume: 10g bottle Number of actuations: 60 sprays ##accordion-item-end## Suitable for Adults aged 18 years and over for the treatment of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. Not suitable for children or adolescents under 18 years of age. Seek medical advice before use if pregnant or breastfeeding. ##accordion-item-end## Warnings and cautions Do not use if you are under 18 years of age. Do not use if you have an untreated infection of the nasal lining such as herpes simplex, or if you have recently had nasal surgery or injury and healing is not yet complete. Seek medical advice before use if you are pregnant or breastfeeding. If your symptoms have not improved after 14 days of use, seek medical advice. Do not use continuously for more than 3 months without consulting a doctor. Seek advice from a doctor or pharmacist before use if you are taking or have recently taken any other medicines, including those obtained without a prescription. Co-treatment with CYP3A inhibitors, including cobicistat-containing products, may increase the risk of systemic side effects. Contains benzalkonium chloride, which may cause irritation or swelling inside the nose, especially with prolonged use. Common side effects include nosebleeds, nasal irritation, nasal burning, headache, and throat irritation. If you experience any visual disturbance, contact your doctor. Always read the patient information leaflet supplied with the product before use. ##accordion-item-end## How to use Before using for the first time, shake the bottle well and prime the pump by pressing it 10 times until a uniform spray appears. If the pump has not been used for 14 days or more, re-prime with 2 actuations before use. Shake the bottle gently before each use. For adults aged 18 and over: use 2 sprays in each nostril once daily. Once symptoms are controlled, reduce to 1 spray in each nostril once daily. Do not use more than 4 sprays (2 in each nostril) per day. If symptoms do not improve after 14 days, stop use and seek medical advice. Discard the bottle within 2 months of first use, even if product remains. ##accordion-item-end## Ingredients Active ingredient: mometasone furoate 50 micrograms per actuation. Also contains: dispersible cellulose (microcrystalline cellulose and carmellose sodium), glycerol, sodium citrate, citric acid monohydrate, polysorbate 80, benzalkonium chloride, purified water. ##accordion-item-end## ##delivery-accordion## ##accordion-end##
Variants (1)
- Default Title — 6.82 GBP — In stock
AI Readiness
Good foundation, but some important product data is still missing.